JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1677/jme.0.0260079
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (87)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rizzoli, R
Right arrow Articles by Ferrari, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rizzoli, R
Right arrow Articles by Ferrari, S.
Journal of Molecular Endocrinology, Vol 26, Issue 2, 79-94
Copyright © 2001 by Society for Endocrinology

Articles

Osteoporosis, genetics and hormones

R Rizzoli, JP Bonjour, and SL Ferrari


Osteoporosis is a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue. At a given age, bone mass results from the amount of bone acquired during growth, i.e. the peak bone mass (Bonjour et al., 1991, Theintz et al. 1992) minus the age-related bone loss which particularly accelerates after menopause. The rate and magnitude of bone mass gain during the pubertal years and of bone loss in later life may markedly differ from one skeletal site to another, as well as from one individual to another. Bone mass gain is mainly related to increases in bone size, that is in bone external dimensions, with minimal changes in bone microarchitecture. In contrast, postmenopausal and age-related decreases in bone mass result from thinning of both cortices and trabeculae, from perforation and eventually disappearance of the latter, leading to significant alterations of the bone microarchitecture (Fig. 1).


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
M. Nilsson, C. Ohlsson, D. Sundh, D. Mellstrom, and M. Lorentzon
Association of Physical Activity with Trabecular Microstructure and Cortical Bone at Distal Tibia and Radius in Young Adult Men
J. Clin. Endocrinol. Metab., June 1, 2010; 95(6): 2917 - 2926.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Behl, M. Siqueira, J. Ortiz, J. Li, T. Desta, D. Faibish, and D. T. Graves
Activation of the Acquired Immune Response Reduces Coupled Bone Formation in Response to a Periodontal Pathogen
J. Immunol., December 15, 2008; 181(12): 8711 - 8718.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
M. R. Tatara
Neonatal programming of skeletal development in sheep is mediated by somatotrophic axis function
Exp Physiol, June 1, 2008; 93(6): 763 - 772.
[Abstract] [Full Text] [PDF]

Home page
 Exp Biol MedHome page
M. R. Tatara, W. Krupski, E. Sliwa, R. Maciejewski, and A. Dabrowski
Fundectomy-Evoked Osteopenia in Pigs Is Mediated by the Gastric-Hypothalamic-Pituitary Axis
Exp Biol Med, December 1, 2007; 232(11): 1449 - 1457.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
U. Kornak, A. Ostertag, S. Branger, O. Benichou, and M.-C. de Vernejoul
Polymorphisms in the CLCN7 Gene Modulate Bone Density in Postmenopausal Women and in Patients with Autosomal Dominant Osteopetrosis Type II
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 995 - 1000.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. A. Schneeweis, D. Willard, and M. E. Milla
Functional Dissection of Osteoprotegerin and Its Interaction with Receptor Activator of NF-{kappa}B Ligand
J. Biol. Chem., December 16, 2005; 280(50): 41155 - 41164.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Ichikawa, D. L. Koller, M. Peacock, M. L. Johnson, D. Lai, S. L. Hui, C. C. Johnston, T. M. Foroud, and M. J. Econs
Polymorphisms in the Estrogen Receptor {beta} (ESR2) Gene Are Associated with Bone Mineral Density in Caucasian Men and Women
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5921 - 5927.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. A. M. Salih, S. Mohan, Y. Kasukawa, G. Tripathi, F. A. Lovett, N. F. Anderson, E. J. Carter, J. E. Wergedal, D. J. Baylink, and J. M. Pell
Insulin-Like Growth Factor-Binding Protein-5 Induces a Gender-Related Decrease in Bone Mineral Density in Transgenic Mice
Endocrinology, February 1, 2005; 146(2): 931 - 940.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. K. Bengtsson, E. J. Ryan, D. Giordano, D. M. Magaletti, and E. A. Clark
17{beta}-Estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells
Blood, September 1, 2004; 104(5): 1404 - 1410.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. L. Ferrari, L. Ahn-Luong, P. Garnero, S. E. Humphries, and S. L. Greenspan
Two Promoter Polymorphisms Regulating Interleukin-6 Gene Expression Are Associated with Circulating Levels of C-Reactive Protein and Markers of Bone Resorption in Postmenopausal Women
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 255 - 259.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Zhang, S. Xuan, M. L. Bouxsein, D. von Stechow, N. Akeno, M. C. Faugere, H. Malluche, G. Zhao, C. J. Rosen, A. Efstratiadis, et al.
Osteoblast-specific Knockout of the Insulin-like Growth Factor (IGF) Receptor Gene Reveals an Essential Role of IGF Signaling in Bone Matrix Mineralization
J. Biol. Chem., November 8, 2002; 277(46): 44005 - 44012.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Endocrinology.